GlassScriptPhysician profile
Jasleen Kukreja
NPI 1174556351
$34,421.55
in general payments reported to CMS, 2019-2025
12 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $5,200 · 2021: $23K · 2022: $1,203 · 2023: $2,170 · 2024: $1,291 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,975 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,974.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $766.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $22,500.00 | 2021 | |
| United Therapeutics Corporation | $5,300.34 | 2020-2025 | Steen Solution |
| Merck Sharp & Dohme LLC | $2,831.67 | 2023-2024 | |
| Xvivo Perfusion INC. | $1,643.11 | 2025 | Xvivo Perfusion System (Xps) |
| Sanofi-Aventis U.S. LLC | $1,202.51 | 2022 | |
| Atricure, INC. | $398.40 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Edwards Lifesciences Corporation | $175.24 | 2023 | Mitris Resilia Mitral Valve |
| La Jolla Pharmaceutical Company | $128.36 | 2023 | Giapreza |
| Intuitive Surgical, INC. | $96.71 | 2019 | |
| Fresenius USA Marketing, INC. | $76.24 | 2023 | Novalung System |
| Davol INC. | $68.97 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasleen Kukreja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.